Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Current Pharmaceutical Design(2)
Advances in Pharmacological Sciences(1)
Archives of Medical Research(1)
Current Psychiatry Research and Reviews(1)
F1000Research(1)
Área temáticas
Enfermedades(6)
Fisiología humana(4)
Ginecología, obstetricia, pediatría, geriatría(1)
Percepción, movimiento, emociones y pulsiones(1)
Problemas sociales y servicios a grupos(1)
Chronobiology and chronotherapy in depression: Current knowledge and chronotherapeutic promises
ArticleAbstract: Background: Depression is a heavily prevalent mental disorder. Symptoms of depression extend beyondPalabras claves:Agomelatine, Chronobiology, Chronodisruption, Chronotherapy, Depression, SleepAutores:Batista M.J., Cano-Ponce C., Chávez-Castillo M., Díaz E.A., González M.C., Ortega A., Pírela D., Riaño M., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusClinical Use of Marijuana: The Thin Line Between Good and Evil?
OtherAbstract: From centuries ago cannabis has been known as a botanic product with several properties, with medicaPalabras claves:cannabis, Ethics, Harm, Marijuana, therapeuticsAutores:Cristobal Ignacio Espinoza Díaz, Rojas M., Salazar-Vílchez J.Fuentes:googlescopusAnti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusDepression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
ReviewAbstract: Depression is currently recognized as a crucial problem in everyday clinical practice, in light of ePalabras claves:Autores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusExploring phytotherapeutic alternatives for obesity, insulin resistance and diabetes mellitus
ReviewAbstract: At present, the pathologic spectrum of obesity-insulin resistance (IR)-diabetes mellitus (DM) repre-Palabras claves:Cardiovascular disease, diabetes mellitus, Insulin Resistance, Medicinal herbs, obesity, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Nuñez V., Ortega A., Pírela D., Rojas M., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusMetabolic syndrome: Is it time to add the central nervous system?
ReviewAbstract: Metabolic syndrome (MS) is a set of cardio-metabolic risk factors that includes central obesity, hypPalabras claves:Alzheimer’s disease, Diabetes mellitus type 2, Insulin Resistance, Metabolic syndrome, Mild cognitive impair-mentAutores:Añez-Ramos R., Chávez-Castillo M., Dávila L.C.A., Díaz-Camargo E.A., Durán-Agüero S., González M.C., Gravini-Donado M., Nava M., Parra H., Pírela D., Rina Ortiz, Rojas M., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusSpecialized pro-resolving lipid mediators: The future of chronic pain therapy?
ReviewAbstract: Chronic pain (CP) is a severe clinical entity with devastating physical and emotional con-sequencesPalabras claves:Central nervous system sensitization, Chronic pain, Eicosanoids, inflammation, Long-term poten-tiation, Nociception, Omega 3 fatty acids, pain management, Polyunsaturated fatty acids, Specialized pro-resolving lipid mediatorsAutores:Chávez-Castillo M., de Sanctis J.B., Durán P., Garrido B., Manzano A., Ortega A., Rojas M., Rojas-Gómez D.M., Salazar-Vílchez J., Silva A., Torres L.C., Valmore BermúdezFuentes:scopus